Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy

OBJECTIVE: To evaluate the survival outcomes and prognostic factors of patients with advanced hepatocellular carcinoma (HCC) who underwent stereotactic ablative radiotherapy (SABR). METHODS: This retrospective study evaluated patients with advanced HCC who underwent SABR between December 2007 and Ju...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Lo, Cheng-Hsiang, Yang, Jen-Fu, Liu, Ming-Yueh, Jen, Yee-Min, Lin, Chun-Shu, Chao, Hsing-Lung, Huang, Wen-Yen
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435316/
https://ncbi.nlm.nih.gov/pubmed/28545098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0177793
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items